127 related articles for article (PubMed ID: 12628661)
1. Cardiovascular hybrid drugs: new benzazepinone derivatives as bradycardic agents endowed with selective beta1-non-competitive antagonism.
Bisi A; Rampa A; Budriesi R; Gobbi S; Belluti F; Ioan P; Valoti E; Chiarini A; Valenti P
Bioorg Med Chem; 2003 Apr; 11(7):1353-61. PubMed ID: 12628661
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological characterization of some benzazepinone derivatives.
Budriesi R; Rampa A; Bisi A; Fabbri G; Chiarini A; Valenti P
Arzneimittelforschung; 1995 Mar; 45(3):234-9. PubMed ID: 7741775
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacological profile of some chloroxanthone-1, 4-dihydropyridine derivatives.
Bisi A; Budriesi R; Rampa A; Fabbri G; Chiarini A; Valenti P
Arzneimittelforschung; 1996 Sep; 46(9):848-51. PubMed ID: 8876931
[TBL] [Abstract][Full Text] [Related]
5. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
[TBL] [Abstract][Full Text] [Related]
6. Specific bradycardic agents. 1. Chemistry, pharmacology, and structure-activity relationships of substituted benzazepinones, a-new class of compounds exerting antiischemic properties.
Reiffen M; Eberlein W; Müller P; Psiorz M; Noll K; Heider J; Lillie C; Kobinger W; Luger P
J Med Chem; 1990 May; 33(5):1496-504. PubMed ID: 2261014
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and cardiovascular properties of fluorenyl derivatives related to verapamil.
Romanelli MN; Teodori E; Scapecchi S; Dei S; Budriesi R; Chiarini A
Farmaco; 1991 Oct; 46(10):1121-38. PubMed ID: 1815578
[TBL] [Abstract][Full Text] [Related]
8. Beta 1- and beta 2-adrenoceptor antagonist activities of ICI-215001, a putative beta 3-adrenoceptor agonist.
Tesfamariam B; Allen GT
Br J Pharmacol; 1994 May; 112(1):55-8. PubMed ID: 7913381
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and cardiodepressant activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-(pentatomic-heteroaryl)-3,5-pyridine-dicarbo xylates. 2.
Baraldi PG; Garuti L; Leoni A; Cacciari B; Budriesi R; Chiarini A
Drug Des Discov; 1993; 10(4):319-29. PubMed ID: 8148471
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological investigations of 1,2,3,4-tetrahydroisoquinoline derivatives.
Brzezinska E; Venter D; Glinka R
Pharmazie; 1996 Jun; 51(6):397-9. PubMed ID: 8767849
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and cardiovascular properties of furazanyl-1,4-dihydropyridines and of furoxanyl analogues.
Gasco AM; Fruttero R; Sorba G; Gasco A; Budriesi R; Chiarini A
Arzneimittelforschung; 1992 Jul; 42(7):921-5. PubMed ID: 1418057
[TBL] [Abstract][Full Text] [Related]
12. Studies on agents with mixed NO-dependent vasodilating and beta-blocking activities.
Boschi D; Di Stilo A; Cena C; Lolli M; Fruttero R; Gasco A
Pharm Res; 1997 Dec; 14(12):1750-8. PubMed ID: 9453064
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and beta-adrenergic properties of (Z)-N-[3-(alkylamino)-2-hydroxypropylidene](aryl-methyloxy)amines: effects of the configuration around the methyloxyiminomethyl (MOIM) double bond on the biopharmacological properties of MOIM-type beta-blocking agents.
Balsamo A; Breschi MC; Chiellini G; Lapucci A; Lazzeri N; Macchia M; Martinelli A; Micali E; Nencetti S; Rossello A
Bioorg Med Chem; 1998 Nov; 6(11):2151-60. PubMed ID: 9881105
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, pharmacological activity and chromatographic separation of some novel potential beta-blockers of the aryloxyaminopropanol type.
Cizmáriková R; Racanská E; Hrobonova K; Lehotay J; Aghová Z; Halesová D
Pharmazie; 2003 Apr; 58(4):237-41. PubMed ID: 12749403
[TBL] [Abstract][Full Text] [Related]
15. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
[TBL] [Abstract][Full Text] [Related]
16. Eugenodilol: a third-generation beta-adrenoceptor blocker, derived from eugenol, with alpha-adrenoceptor blocking and beta2-adrenoceptor agonist-associated vasorelaxant activities.
Huang YC; Wu BN; Lin YT; Chen SJ; Chiu CC; Cheng CJ; Chen IJ
J Cardiovasc Pharmacol; 1999 Jul; 34(1):10-20. PubMed ID: 10413061
[TBL] [Abstract][Full Text] [Related]
17. Hypotensive effects of eugenosedin-A with serotonin, alpha- and beta-adrenoceptor antagonistic activities in spontaneously hypertensive and normotensive rats.
Shen KP; Chiu CC; Chen SJ; Chen IJ; Wu BN
Pharmacology; 2004 Jun; 71(2):91-101. PubMed ID: 15118348
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological effects of an aldehyde type alpha/beta-adrenoceptor blocking agent with vasodilating properties.
Chiu CC; Lin YT; Tsai CH; Liang JC; Chiang LC; Wu JR; Chen IJ; Yeh JL
Gen Pharmacol; 2000 Jun; 34(6):391-400. PubMed ID: 11483288
[TBL] [Abstract][Full Text] [Related]
19. Enantiomers of 8-(3-tert-butylamino-2-hydroxypropoxy)-3,4-dihydro-3-oxo-2H- (1,4)benzothiazine: racemic resolution, chiral synthesis and biological activity.
Schiaffella F; Fringuelli R; Cecchetti V; Fravolini A; Angeli P; Marucci G
Farmaco; 1990 Dec; 45(12):1299-307. PubMed ID: 1982489
[TBL] [Abstract][Full Text] [Related]
20. Isoeugenolol: a selective beta1-adrenergic antagonist with tracheal and vascular smooth muscle relaxant properties.
Lin YT; Wu BN; Horng CF; Huang YC; Hong SJ; Lo YC; Cheng CJ; Chen IJ
Jpn J Pharmacol; 1999 Jun; 80(2):127-36. PubMed ID: 10440531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
